Royal Bank of Canada
INSM icon

Royal Bank of Canada’s Insmed INSM Stock Holding History

Royal Bank of Canada’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.5M Buy
523,101
+16,290
+3% +$2.5M 0.02% 692
2025
Q4 		$88.2M Sell
506,811
-848,520
-63% -$155M 0.01% 702
2025
Q3 		$195M Buy
1,355,331
+927,530
+217% +$114M 0.03% 435
2025
Q2 		$43.1M Buy
427,801
+182,539
+74% +$14M 0.01% 1021
2025
Q1 		$18.7M Buy
245,262
+61,190
+33% +$4.68M ﹤0.01% 1349
2024
Q4 		$12.7M Sell
184,072
-16,364
-8% -$1.18M ﹤0.01% 1651
2024
Q3 		$14.6M Buy
200,436
+11,360
+6% +$838K ﹤0.01% 1544
2024
Q2 		$12.7M Buy
189,076
+151,628
+405% +$5.88M ﹤0.01% 1526
2024
Q1 		$1.01M Sell
37,448
-35,707
-49% -$999K ﹤0.01% 3459
2023
Q4 		$2.27M Buy
73,155
+4,332
+6% +$112K ﹤0.01% 2973
2023
Q3 		$1.74M Buy
68,823
+19,111
+38% +$437K ﹤0.01% 2970
2023
Q2 		$1.05M Sell
49,712
-6,017
-11% -$114K ﹤0.01% 3336
2023
Q1 		$950K Buy
55,729
+1,477
+3% +$28.7K ﹤0.01% 3378
2022
Q4 		$1.08M Buy
54,252
+25,791
+91% +$499K ﹤0.01% 3434
2022
Q3 		$613K Buy
28,461
+1,065
+4% +$25.5K ﹤0.01% 3846
2022
Q2 		$541K Sell
27,396
-8,583
-24% -$180K ﹤0.01% 4017
2022
Q1 		$846K Sell
35,979
-13,166
-27% -$306K ﹤0.01% 3802
2021
Q4 		$1.34M Buy
49,145
+13,042
+36% +$373K ﹤0.01% 3531
2021
Q3 		$994K Sell
36,103
-56,127
-61% -$1.47M ﹤0.01% 3701
2021
Q2 		$2.62M Sell
92,230
-67,835
-42% -$2.01M ﹤0.01% 2828
2021
Q1 		$5.45M Buy
160,065
+144,887
+955% +$5.54M ﹤0.01% 2182
2020
Q4 		$505K Buy
15,178
+8,456
+126% +$309K ﹤0.01% 4129
2020
Q3 		$216K Buy
6,722
+5,826
+650% +$167K ﹤0.01% 4496
2020
Q2 		$25K Sell
896
-290
-24% -$6.88K ﹤0.01% 5493
2020
Q1 		$19K Sell
1,186
-7,414
-86% -$176K ﹤0.01% 5571
2019
Q4 		$206K Buy
8,600
+7,290
+556% +$148K ﹤0.01% 4618
2019
Q3 		$23K Buy
1,310
+368
+39% +$7.11K ﹤0.01% 5442
2019
Q2 		$24K Buy
942
+900
+2,143% +$25.1K ﹤0.01% 5623
2019
Q1 		$1K Sell
42
-500
-92% -$13K ﹤0.01% 6651
2018
Q4 		$7K Sell
542
-1,980
-79% -$31.6K ﹤0.01% 6036
2018
Q3 		$51K Buy
2,522
+1,915
+315% +$43.2K ﹤0.01% 5223
2018
Q2 		$14K Buy
607
+500
+467% +$12.9K ﹤0.01% 5704
2018
Q1 		$2K Sell
107
-393
-79% -$10.3K ﹤0.01% 6111
2017
Q4 		$15K Sell
500
-6,317
-93% -$187K ﹤0.01% 5707
2017
Q3 		$213K Buy
6,817
+6,583
+2,813% +$125K ﹤0.01% 4473
2017
Q2 		$4K Sell
234
-2,059
-90% -$35.2K ﹤0.01% 6112
2017
Q1 		$40K Sell
2,293
-6,308
-73% -$97.3K ﹤0.01% 5261
2016
Q4 		$113K Buy
8,601
+3,590
+72% +$49K ﹤0.01% 4812
2016
Q3 		$73K Sell
5,011
-1,096
-18% -$13.7K ﹤0.01% 4975
2016
Q2 		$60K Buy
6,107
+107
+2% +$1.25K ﹤0.01% 5030
2016
Q1 		$76K Buy
6,000
+5,906
+6,283% +$77.6K ﹤0.01% 4890
2015
Q4 		$2K Sell
94
-3,274
-97% -$57.7K ﹤0.01% 6359
2015
Q3 		$63K Buy
3,368
+2,960
+725% +$73.9K ﹤0.01% 5026
2015
Q2 		$10K Buy
408
+100
+32% +$2.27K ﹤0.01% 6043
2015
Q1 		$6K Buy
308
+70
+29% +$1.23K ﹤0.01% 5688
2014
Q4 		$4K Hold
238
– – ﹤0.01% 5853
2014
Q3 		$3K Hold
238
– – ﹤0.01% 5744
2014
Q2 		$5K Buy
+238
New +$3.52K ﹤0.01% 5564
2013
Q4 		– Sell
-438
Closed -$7K – 6021
2013
Q3 		$7K Buy
438
+338
+338% +$4.29K ﹤0.01% 5532
2013
Q2 		$1K Buy
+100
New +$1.02K ﹤0.01% 5720

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Royal Bank of Canada's INSM Position: Q1 2026 in Review

Royal Bank of Canada increased its Insmed (INSM) stake by 3.2% in Q1 2026, buying an estimated $2.5M and bringing the position to 523,101 shares worth $85.5M. The position accounts for 0.02% of the portfolio, ranked #692.

Royal Bank of Canada first reported a position in INSM in Q2 2013 and has held it in 50 quarters since. The position peaked at $195M in Q3 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Royal Bank of Canada held 523,101 shares of Insmed worth $85.5M as of Q1 2026.
  • Royal Bank of Canada bought 16,290 Insmed shares in Q1 2026, an estimated $2.5M.
  • Insmed made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #692 holding.
  • Royal Bank of Canada first reported a position in Insmed in Q2 2013 and has held it in 50 quarters since.
  • Royal Bank of Canada's Insmed position peaked at $195M in Q3 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.